These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 12467061

  • 1. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik OW.
    Cancer; 2002 Dec 15; 95(12):2487-93. PubMed ID: 12467061
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA, Quast BJ, Reddy PK, Lall V, Wilson MJ, Qian J, Bostwick DG.
    Exp Mol Pathol; 2004 Oct 15; 77(2):153-9. PubMed ID: 15351240
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 15; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J, Epstein JI.
    Am J Surg Pathol; 2009 Apr 15; 33(4):583-90. PubMed ID: 19033862
    [Abstract] [Full Text] [Related]

  • 9. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F, Epstein JI.
    Am J Surg Pathol; 2008 Jul 15; 32(7):1060-7. PubMed ID: 18496142
    [Abstract] [Full Text] [Related]

  • 10. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer.
    Wullich B, Rohde V, Oehlenschläger B, Bonkhoff H, Ketter R, Zwergel T, Sattler HP.
    J Urol; 1999 Jun 15; 161(6):1997-2001. PubMed ID: 10332489
    [Abstract] [Full Text] [Related]

  • 11. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU, Haber MM, Chen X.
    Prostate; 2007 Nov 01; 67(15):1686-92. PubMed ID: 17879949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
    Shah RB, Magi-Galluzzi C, Han B, Zhou M.
    Am J Surg Pathol; 2010 Apr 01; 34(4):470-7. PubMed ID: 20182345
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
    Paradis V, Dargère D, Laurendeau I, Benoît G, Vidaud M, Jardin A, Bedossa P.
    J Pathol; 1999 Oct 01; 189(2):213-8. PubMed ID: 10547577
    [Abstract] [Full Text] [Related]

  • 16. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
    Koeneman KS, Pan CX, Jin JK, Pyle JM, Flanigan RC, Shankey TV, Diaz MO.
    J Urol; 1998 Oct 01; 160(4):1533-9. PubMed ID: 9751408
    [Abstract] [Full Text] [Related]

  • 17. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML.
    Clin Cancer Res; 1999 Dec 01; 5(12):4105-10. PubMed ID: 10632347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate.
    Willman JH, Holden JA.
    Prostate; 2000 Mar 01; 42(4):280-6. PubMed ID: 10679757
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.
    Am J Surg Pathol; 2007 Aug 01; 31(8):1246-55. PubMed ID: 17667550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.